The rat red blood cell proteome is altered by priming with 2-butoxyethanol

Toxicology and Applied Pharmacology

Volumn 230, Issue 3, 2008, Pages 338-345

  Palkar, Prajakta S ^a   Kakhniashvili, David G ^b   Goodman, Steven R ^b   Mehendale, Harihara M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

2 Butoxyethanol; Autoprotection; Proteomics; Red blood cells

Indexed keywords

2 BUTOXYETHANOL; ANTIOXIDANT; CELL PROTEIN; CY3 FLUOROPHORE; CY5 FLUOROPHORE; FLUORESCENT DYE; PROTEOME;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENERGY METABOLISM; HEMOLYSIS; LIPID RAFT; NONHUMAN; PROTEIN METABOLISM; PROTEOMICS; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; BLOOD PROTEINS; CATALASE; CYTOSOL; ENERGY METABOLISM; ERYTHROCYTES; ETHYLENE GLYCOLS; FEMALE; GLUTATHIONE; HEMATOCRIT; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 46749108784     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.03.005     Document Type: Article

References (40)

1. Barton C.C., Bucci T.J., Lomax L.G., Warbritton A.G., and Mehendale H.M. Stimulated pulmonary cell hyperplasia underlies resistance to alpha-naphthylthiourea. Toxicology 143 (2000) 167-181
2. Beutler E. Drug-induced hemolytic anemia. Pharmacol. Rev. 21 (1969) 73-103
3. Cahill D.J., Nordhoff E., O'Brien J., Klose J., Eickhoff H., and Lehrach H. Bridging genomics and proteomics. In: Pennington S.R., and Dunn M.J. (Eds). Proteomics: From Protein Sequence to Function (2001), Springer-Verlag Telos 1-19
4. Candas M., Loseva O., Oppert B., Kosaraju P., and Bulla Jr. L.A. Insect resistance to Bacillus thuringiensis: alterations in the indianmeal moth larval gut proteome. Mol. Cell. Proteomics 2 (2003) 19-28
5. Chen H., Khan A.A., Liu F., Gilligan D.M., Peters L.L., Messick J., Haschek-Hock W.M., Li X., Ostafin A.E., and Chishti A.H. Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia. J. Biol. Chem. 282 (2007) 4124-4135
6. Dalhoff K., Laursen H., Bangert K., Poulsen H.E., Anderson M.E., Grunnet N., and Tygstrup N. Autoprotection in acetaminophen intoxication in rats: the role of liver regeneration. Pharmacol. Toxicol. 88 (2001) 135-141
7. Dariyerli N., Toplan S., Akyolcu M.C., Hatemi H., and Yigit G. Erythrocyte osmotic fragility and oxidative stress in experimental hypothyroidism. Endocrine 25 (2004) 1-5
8. Devi S.S., Philip B.K., Warbritton A., Latendresse J.R., and Mehendale H.M. Prior administration of a low dose of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide. Toxicology 226 (2006) 107-117
9. Ghanayem B.I. Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro. Biochem. Pharmacol. 38 (1989) 1679-1684
10. Ghanayem B.I., and Sullivan C.A. Assessment of the haemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Hum. Exp. Toxicol. 12 (1993) 305-311
11. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
12. Goodman S.R., Kurdia A., Ammann L., Kakhniashvili D., and Daescu O. The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 232 (2007) 1391-1408
13. Grattagliano I., Russmann S., Palmieri V.O., Portincasa P., Palasciano G., and Lauterburg B.H. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin. Pharmacol. Ther. 78 (2005) 422-432
14. Grunnet N., Tygstrup N., and Dich J. Autoprotection against acetaminophen toxicity in cultured rat hepatocytes: the effect of pretreatment and growth factors. Pharmacol. Toxicol. 93 (2003) 135-141
15. Hodges S.D., Fung E., McKay D.J., Renaux B.S., and Snyder F.F. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells. J. Biol. Chem. 264 (1989) 18137-18141
16. Kakhniashvili D.G., Bulla Jr. L.A., and Goodman S.R. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol. Cell. Proteomics 3 (2004) 501-509
17. Khanna R., Chang S.H., Andrabi S., Azam M., Kim A., Rivera A., Brugnara C., Low P.S., Liu S.C., and Chishti A.H. Headpiece domain of dematin is required for the stability of the erythrocyte membrane. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6637-6642
18. Kim Y.M., Bergonia H., and Lancaster Jr. J.R. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett. 374 (1995) 228-232
19. King K.E., and Ness P.M. Treatment of autoimmune hemolytic anemia. Semin. Hematol. 42 (2005) 131-136
20. Kobayashi K., Lin L.W., Yeadon J.E., Klickstein L.B., and Smith J.A. Cloning and sequence analysis of a rat liver cDNA encoding acyl-peptide hydrolase. J. Biol. Chem. 264 (1989) 8892-8899
21. Korrapati M.C., Lock E.A., and Mehendale H.M. Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-l-cysteine-induced acute renal failure and death. Am. J. Physiol. Renal Physiol. 289 (2005) F175-F185
22. Korrapati M.C., Chilakapati J., Lock E.A., Latendresse J.R., Warbritton A., and Mehendale H.M. Preplaced cell division - A critical mechanism of autoprotection against S-1,2-dichlorovinyl-l-cysteine-induced acute renal failure and death in mice. Am. J. Physiol. Renal Physiol. 291 (2006) F439-F455
23. Korrapati M.C., Chilakapati J., Witzmann F.A., Rao C., Lock E.A., and Mehendale H.M. Proteomics of S-(1, 2-dichlorovinyl)-l-cysteine-induced acute renal failure and autoprotection in mice. Am. J. Physiol. Renal Physiol. 293 (2007) F994-F1006
24. Low T.Y., Seow T.K., and Chung M.C. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2 (2002) 1229-1239
25. Low F.M., Hampton M.B., Peskin A.V., and Winterbourn C.C. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109 (2007) 2611-2617
26. Mehendale H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33 (2005) 41-51
27. Mehendale H.M., and Limaye P.B. Calpain: a death protein that mediates progression of liver injury. Trends Pharmacol. Sci. 26 (2005) 232-236
28. Mehendale H.M., Thakore K.N., and Rao C.V. Autoprotection: stimulated tissue repair permits recovery from injury. J. Biochem. Toxicol. 9 (1994) 131-139
29. Muro A.F., Marro M.L., Gajovic S., Porro F., Luzzatto L., and Baralle F.E. Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood 95 (2000) 3978-3985
30. Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
31. Palkar P.S., Philip B.K., Reddy R.N., and Mehendale H.M. Priming dose of phenylhydrazine protects against hemolytic and lethal effects of 2-butoxyethanol. Toxicol. Appl. Pharmacol. 225 (2007) 102-112
32. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., Thomas A.W., and Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
33. Peters L.L., Shivdasani R.A., Liu S.C., Hanspal M., John K.M., Gonzalez J.M., Brugnara C., Gwynn B., Mohandas N., Alper S.L., Orkin S.H., and Lux S.E. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell 86 (1996) 917-927
34. Philip B.K., Anand S.S., Palkar P.S., Mumtaz M.M., Latendresse J.R., and Mehendale H.M. Subchronic chloroform priming protects mice from a subsequently administered lethal dose of chloroform. Toxicol. Appl. Pharmacol. 216 (2006) 108-121
35. Pickart C.M., and Vella A.T. Levels of active ubiquitin carrier proteins decline during erythroid maturation. J. Biol. Chem. 263 (1988) 12028-12035
36. Sawant S.D., Doucet P.G., Slob W., Blaylock B.L., and Mehendale H.M. Experimental mathematical validation of a novel concept of extended 2-butoxyethanol autoprotection. Internat. J. Toxicol. 18 (1999) 307-316
37. Shi Z.T., Afzal V., Coller B., Patel D., Chasis J.A., Parra M., Lee G., Paszty C., Stevens M., Walensky L., Peters L.L., Mohandas N., Rubin E., and Conboy J.G. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J. Clin. Invest. 103 (1999) 331-340
38. Sivarao D.V., and Mehendale H.M. 2-Butoxyethanol autoprotection is due to resiliance of newly formed erythrocytes to hemolysis. Arch. Toxicol. 69 (1995) 526-532
39. Vaidya V.S., Shankar K., Lock E.A., Bucci T.J., and Mehendale H.M. Role of tissue repair in survival from s-(1,2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol. Sci. 74 (2003) 215-227
40. Walensky L.D., Narla M., and Lux S.E. Disorders of the red cell membrane. In: Handlin R.I., Lux S.E., and Stossel T.P. (Eds). Blood: Principles and practice of hematology (2003), Williams, & Wilkins, Lippincott 1709-1858